Bristol-Myers Squibb (BMS) makes drugs for the brain, heart, and other body parts. The biopharmaceutical's blockbuster lineup includes rhemuatoid arthritis treatment Orencia and ELIQUIS for stroke prevention. BMS also makes antipsychotic medication Abilify and HIV treatments Reyataz and Sustiva. Most of its sales come from products in the therapeutic areas of cardiovascular care, hepatitis, immunology, metabolics, neuroscience, oncology, and virology. BMS has global research facilities and manufacturing plants, mainly in the US and Europe, and its products are marketed to health care practitioners, hospitals, and managed care providers in 100 countries.